Personalized medicine in a phase I clinical trials program: The M. D. Anderson Cancer Center Initiative.
نویسندگان
چکیده
CRA2500 The full, final text of this abstract will be available in Part II of the 2011 Annual Meeting Proceedings, distributed onsite at the Meeting on June 4, 2011, and as a supplement to the June 20, 2011, issue of Journal of Clinical Oncology.
منابع مشابه
CROSSING THE WAY OF PRECISION MEDICINE APPROACH IN PERSONALIZED MEDICINE RESEARCH CENTER: A SYSTEMATIC REVIEW
Background: Precision medicine is a new approach in the field of medical sciences that utilizes the genetic characteristics of each patient along with clinical information to guide decisions related to diagnosis and early treatment of diseases. The Personalized Medicine Research Center, as the only center approved by the Ministry of Health, is working on precision medicine context and producing...
متن کاملBayesian clinical trials at the University of Texas M. D. Anderson Cancer Center.
BACKGROUND The Bayesian approach is being used increasingly in medical research. In particular, it has become a standard in designing clinical trials at the University of Texas M. D. Anderson Cancer Center. PURPOSE / METHODS To address the extent and nature of Bayesian trials conducted at M. D. Anderson, we reviewed the protocols registered in the Protocol Document Online System between 200...
متن کاملIt is time to include patients with brain tumors in phase I trials in oncology.
Patrick Y. Wen, Center for Neuro-Oncology, Dana-Farber Cancer Institute; Brigham and Women’s Hospital, Boston, MA David Schiff, Neuro-Oncology Center, University of Virginia, Charlottesville, VA Timothy F. Cloughesy, Neuro-Oncology Program, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA David A. Reardon, Preston Robert Tisch Brain Tumor Center, Duke Un...
متن کاملThe importance of personalized medicine in urological cancers
Personalized medicine (PM) refers to a set of medical, diagnostic, and therapeutic activities and approaches based on the specific characteristics of each patient chr ('39')s genome. In fact, individual-centered medical approaches are based on personalization, meaning that each person chr ('39')s gene sequence and polymorphisms (SNPs) are different and explain the different courses of urologica...
متن کاملHuman Cancer Modeling: Recapitulating Tumor Heterogeneity Towards Personalized Medicine
Despite diagnostic, preventive and therapeutic advances, growing incidence of cancer and high rate of mortality among patients affected by specific cancer types indicate current clinical measures are not ideally useful in eradicating cancer. Chemoresistance and subsequent disease relapse are believed to be mainly driven by the cell-molecular heterogeneity of human tumors that necessitates perso...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
دوره 29 18_suppl شماره
صفحات -
تاریخ انتشار 2011